GoHealth Announces Board and Executive Changes

Ticker: GOCO · Form: 8-K · Filed: Oct 10, 2024 · CIK: 1808220

Gohealth, Inc. 8-K Filing Summary
FieldDetail
CompanyGohealth, Inc. (GOCO)
Form Type8-K
Filed DateOct 10, 2024
Risk Levelmedium
Pages6
Reading Time7 min
Key Dollar Amounts$0.0001, $500,000, $50,000, $400,000, $162,500
Sentimentneutral

Sentiment: neutral

Topics: management-change, compensation

Related Tickers: GOCO

TL;DR

GoHealth shakes up its board and exec pay structure, effective Oct 4.

AI Summary

GoHealth, Inc. announced on October 4, 2024, changes in its board of directors and executive compensation arrangements. Specifically, the company reported the departure of certain officers and directors, the election of new directors, and adjustments to the compensatory arrangements for its named executive officers. These changes are effective as of October 4, 2024.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in leadership and compensation can introduce uncertainty regarding future strategy and operational stability.

Key Players & Entities

  • GoHealth, Inc. (company) — Registrant
  • October 4, 2024 (date) — Effective date of reported changes

FAQ

Who are the specific officers and directors who have departed from GoHealth, Inc.?

The filing indicates the departure of certain officers and directors but does not name them specifically in the provided text.

Who are the newly elected directors to GoHealth, Inc.'s board?

The filing mentions the election of new directors but does not provide their names in the provided text.

What specific changes have been made to the compensatory arrangements of certain officers?

The filing states that there have been adjustments to compensatory arrangements but does not detail the specifics of these changes in the provided text.

What is the effective date of these reported changes?

The effective date for the departure of directors/officers, election of directors, and changes to compensatory arrangements is October 4, 2024.

What is the primary business of GoHealth, Inc. according to the filing?

GoHealth, Inc. is classified under INSURANCE AGENTS BROKERS & SERVICES [6411].

Filing Stats: 1,864 words · 7 min read · ~6 pages · Grade level 12.3 · Accepted 2024-10-10 09:02:57

Key Financial Figures

  • $0.0001 — which registered Class A Common Stock, $0.0001 par value per share GOCO The Nasdaq Glo
  • $500,000 — to receive (i) an annual base salary of $500,000, (ii) discretionary annual cash bonuses
  • $50,000 — . Shanahan will also receive a one-time $50,000 signing bonus within 30 days of the Eff
  • $400,000 — to receive (i) an annual base salary of $400,000, (ii) discretionary annual cash bonuses
  • $162,500 — . O'Halloran shall receive a minimum of $162,500 for the 2024 annual bonus, payable in 2

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On October 10, 2024, the Company issued a press release announcing the appointment of Mr. Shanahan as the Company's Chief Financial Officer and Ms. O'Halloran's continuation of service to the Company as its Chief Accounting Officer. A copy of the press release filed with this Current Report on Form 8-K is furnished as Exhibit 99.1 hereto and incorporated into this Item 7.01 by reference. The information in this Item 7.01 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, as amended (the "Exchange Act") or otherwise subject to liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such disclosure in this Current Report on Form 8-K in such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. The following exhibits are included herewith: Exhibit Number Description 10.1 Employment Agreement, dated as of October 4, 2024, by and among Brendan Shanahan, GoHealth, Inc. and Norvax, LLC 10.2 Employment Agreement, dated as of October 4, 2024, by and among Katherine O'Halloran and Norvax, LLC 99.1 Press Release of GoHealth, Inc., dated October 10, 2024 104 Cover Page Interactive Data File (formatted as inline XBRL)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GOHEALTH, INC. Date: October 10, 2024 By: /s/ Brad Burd Brad Burd Chief Legal Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.